Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer (Nature Communications, (2019), 10, 1, (4682), 10.1038/s41467-019-12657-w)

Katherine A. Michaelis, Mason A. Norgard, Xinxia Zhu, Peter R. Levasseur, Shamilene Sivagnanam, Shannon M. Liudahl, Kevin G. Burfeind, Brennan Olson, Katherine R. Pelz, Diana M.Angeles Ramos, H. Carlo Maurer, Kenneth P. Olive, Lisa M. Coussens, Terry K. Morgan, Daniel L. Marks

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

The original HTML and PDF of this Article contained errors in Figs. 3 and 4. All panels for Figures 3 and 4 were inadvertently inverted. This has been corrected in both the HTML and PDF versions of the Article.

Original languageEnglish (US)
Article number5257
JournalNature communications
Volume10
Issue number1
DOIs
StatePublished - Dec 1 2019

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Fingerprint Dive into the research topics of 'Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer (Nature Communications, (2019), 10, 1, (4682), 10.1038/s41467-019-12657-w)'. Together they form a unique fingerprint.

  • Cite this

    Michaelis, K. A., Norgard, M. A., Zhu, X., Levasseur, P. R., Sivagnanam, S., Liudahl, S. M., Burfeind, K. G., Olson, B., Pelz, K. R., Ramos, D. M. A., Maurer, H. C., Olive, K. P., Coussens, L. M., Morgan, T. K., & Marks, D. L. (2019). Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer (Nature Communications, (2019), 10, 1, (4682), 10.1038/s41467-019-12657-w). Nature communications, 10(1), [5257]. https://doi.org/10.1038/s41467-019-13151-z